Skip to content
Clinical Trials – home
Kamada Ltd.
Sponsor

Kamada Ltd.

2 Holzman Haim Street, 7670402

About the sponsor

Kamada Ltd. is engaged in clinical research for adults with congenital alpha-1 antitrypsin deficiency, with attention to patients who have moderate to severe airflow limitation and reduced pulmonary function.

  • Congenital alpha-1 antitrypsin deficiency
  • Adult respiratory disease
  • Pulmonary function impairment

The sponsor’s research focus in this area centers on chronic lung disease associated with inherited protein deficiency.

About Specializations

Kamada Ltd. runs clinical trials in conditions such as Alpha-1 antitrypsin deficiency, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Study of inhaled alpha1-proteinase inhibitor (Kamada-AAT) in adults with alpha-1 antitrypsin deficiency and moderate to severe airflow limitation

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:ALPHA-1-ANTITRYPSIN
  • Sponsor:Kamada Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.